Binds to PHD2, preventing the interaction of PHD2-HIF-1a and thus inhibits the hydroxylation and degradation of HIF-1a, which leads to the increase of aerobic glycolysis. Protects tumor cells from apoptosis. The gene discussed is EGLN1; the disease is neoplasm.